Susquehanna Fundamental Investments’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,190
Closed -$971K 903
2025
Q1
$971K Hold
9,190
0.01% 693
2024
Q4
$889K Buy
+9,190
New +$916K 0.01% 739
2024
Q2
$756K Buy
+8,800
New +$692K 0.02% 607
2023
Q3
Sell
-9,317
Closed -$779K 507
2023
Q2
$779K Sell
9,317
-300
-3% -$24.4K 0.03% 373
2023
Q1
$711K Sell
9,617
-2,661
-22% -$187K 0.02% 596
2022
Q4
$867K Buy
+12,278
New +$820K 0.02% 690
2022
Q1
$3.1M Buy
46,642
+36,577
+363% +$2.2M 0.06% 439
2021
Q4
$627K Sell
10,065
-26,847
-73% -$1.8M 0.02% 833
2021
Q3
$2.65M Buy
36,912
+18,367
+99% +$1.25M 0.05% 512
2021
Q2
$1.2M Sell
18,545
-29,980
-62% -$1.85M 0.02% 775
2021
Q1
$2.91M Sell
48,525
-16,003
-25% -$917K 0.05% 509
2020
Q4
$3.58M Buy
64,528
+26,028
+68% +$1.34M 0.07% 431
2020
Q3
$1.68M Sell
38,500
-19,400
-34% -$877K 0.05% 486
2020
Q2
$2.64M Buy
+57,900
New +$2.34M 0.13% 199

Other funds holding MMSI

Susquehanna Fundamental Investments's MMSI Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Merit Medical Systems (MMSI) in Q2 2025, closing a stake of 9,190 shares — an estimated $971K sold.

Susquehanna Fundamental Investments first reported a position in MMSI in Q2 2020 and held it in 14 quarters. The position peaked at $3.58M in Q4 2020. 379 funds tracked by Wall St. Rank hold MMSI as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Merit Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 9,190 Merit Medical Systems shares in Q2 2025, an estimated $971K.
  • Susquehanna Fundamental Investments first reported a position in Merit Medical Systems in Q2 2020 and held it in 14 quarters.
  • Susquehanna Fundamental Investments's Merit Medical Systems position peaked at $3.58M in Q4 2020.
  • 379 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.